nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—Signaling Pathways—TP53—bile duct cancer	0.000542	0.000542	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000541	0.000541	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—EGFR—bile duct cancer	0.000529	0.000529	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—EGFR—bile duct cancer	0.000529	0.000529	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	0.000528	0.000528	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	0.000528	0.000528	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—GNAS—bile duct cancer	0.000522	0.000522	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—HRAS—bile duct cancer	0.000518	0.000518	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TGFBR2—bile duct cancer	0.000516	0.000516	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—KRAS—bile duct cancer	0.000516	0.000516	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—IDH1—bile duct cancer	0.000514	0.000514	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—GNAS—bile duct cancer	0.000505	0.000505	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—GNAS—bile duct cancer	0.000505	0.000505	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—KRAS—bile duct cancer	0.0005	0.0005	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—KRAS—bile duct cancer	0.0005	0.0005	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—GNAS—bile duct cancer	0.000498	0.000498	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—IL6—bile duct cancer	0.000496	0.000496	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—SMAD4—bile duct cancer	0.000489	0.000489	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—SLC5A5—bile duct cancer	0.000488	0.000488	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.00048	0.00048	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—NRAS—bile duct cancer	0.000476	0.000476	CbGpPWpGaD
Loperamide—CALM3—Metabolism—SLC5A5—bile duct cancer	0.000475	0.000475	CbGpPWpGaD
Loperamide—CALM2—Metabolism—SLC5A5—bile duct cancer	0.000459	0.000459	CbGpPWpGaD
Loperamide—CALM1—Metabolism—SLC5A5—bile duct cancer	0.000459	0.000459	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFBR2—bile duct cancer	0.000457	0.000457	CbGpPWpGaD
Loperamide—CALM3—Immune System—HGF—bile duct cancer	0.000454	0.000454	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—ERBB2—bile duct cancer	0.00045	0.00045	CbGpPWpGaD
Loperamide—CALM3—Neuronal System—HRAS—bile duct cancer	0.000448	0.000448	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFBR2—bile duct cancer	0.000442	0.000442	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFBR2—bile duct cancer	0.000442	0.000442	CbGpPWpGaD
Loperamide—CALM2—Immune System—HGF—bile duct cancer	0.00044	0.00044	CbGpPWpGaD
Loperamide—CALM1—Immune System—HGF—bile duct cancer	0.00044	0.00044	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—HRAS—bile duct cancer	0.000439	0.000439	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—ERBB2—bile duct cancer	0.000435	0.000435	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—ERBB2—bile duct cancer	0.000435	0.000435	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—EGFR—bile duct cancer	0.000433	0.000433	CbGpPWpGaD
Loperamide—CALM2—Neuronal System—HRAS—bile duct cancer	0.000433	0.000433	CbGpPWpGaD
Loperamide—CALM1—Neuronal System—HRAS—bile duct cancer	0.000433	0.000433	CbGpPWpGaD
Loperamide—CALM3—Disease—SMAD4—bile duct cancer	0.000432	0.000432	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—ERBB2—bile duct cancer	0.000432	0.000432	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—HRAS—bile duct cancer	0.000425	0.000425	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—HRAS—bile duct cancer	0.000425	0.000425	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—IL6—bile duct cancer	0.00042	0.00042	CbGpPWpGaD
Loperamide—CALM1—Disease—SMAD4—bile duct cancer	0.000418	0.000418	CbGpPWpGaD
Loperamide—CALM2—Disease—SMAD4—bile duct cancer	0.000418	0.000418	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—ERBB2—bile duct cancer	0.000418	0.000418	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—ERBB2—bile duct cancer	0.000418	0.000418	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—NRAS—bile duct cancer	0.000417	0.000417	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—SLC5A5—bile duct cancer	0.000413	0.000413	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—KRAS—bile duct cancer	0.000409	0.000409	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—IL6—bile duct cancer	0.000406	0.000406	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—IL6—bile duct cancer	0.000406	0.000406	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—IDH2—bile duct cancer	0.000391	0.000391	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000387	0.000387	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—NRAS—bile duct cancer	0.00038	0.00038	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—EGFR—bile duct cancer	0.00038	0.00038	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GNAS—bile duct cancer	0.000379	0.000379	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—ERBB2—bile duct cancer	0.000369	0.000369	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GNAS—bile duct cancer	0.000369	0.000369	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—NRAS—bile duct cancer	0.000368	0.000368	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—NRAS—bile duct cancer	0.000368	0.000368	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—SLC5A5—bile duct cancer	0.00036	0.00036	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—KRAS—bile duct cancer	0.000359	0.000359	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GNAS—bile duct cancer	0.000357	0.000357	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GNAS—bile duct cancer	0.000357	0.000357	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TGFB1—bile duct cancer	0.000353	0.000353	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—NRAS—bile duct cancer	0.000352	0.000352	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—HRAS—bile duct cancer	0.000348	0.000348	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—NRAS—bile duct cancer	0.000342	0.000342	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TGFB1—bile duct cancer	0.000342	0.000342	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TGFB1—bile duct cancer	0.000342	0.000342	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—SLC5A5—bile duct cancer	0.000339	0.000339	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—IDH1—bile duct cancer	0.000336	0.000336	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—IL6—bile duct cancer	0.000333	0.000333	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—NRAS—bile duct cancer	0.000331	0.000331	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—NRAS—bile duct cancer	0.000331	0.000331	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—NRAS—bile duct cancer	0.000329	0.000329	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—KRAS—bile duct cancer	0.000327	0.000327	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—ERBB2—bile duct cancer	0.000324	0.000324	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS2—bile duct cancer	0.000322	0.000322	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—EGFR—bile duct cancer	0.000321	0.000321	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GNAS—bile duct cancer	0.000321	0.000321	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFBR2—bile duct cancer	0.00032	0.00032	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—NRAS—bile duct cancer	0.000318	0.000318	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—NRAS—bile duct cancer	0.000318	0.000318	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MMP9—bile duct cancer	0.000317	0.000317	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—KRAS—bile duct cancer	0.000316	0.000316	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—KRAS—bile duct cancer	0.000316	0.000316	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—EGFR—bile duct cancer	0.000312	0.000312	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS2—bile duct cancer	0.000311	0.000311	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS2—bile duct cancer	0.000311	0.000311	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFBR2—bile duct cancer	0.000309	0.000309	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFBR2—bile duct cancer	0.000309	0.000309	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—GNAS—bile duct cancer	0.000308	0.000308	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—HRAS—bile duct cancer	0.000305	0.000305	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—KRAS—bile duct cancer	0.000303	0.000303	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SMAD4—bile duct cancer	0.000303	0.000303	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—EGFR—bile duct cancer	0.000302	0.000302	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—EGFR—bile duct cancer	0.000302	0.000302	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—EGFR—bile duct cancer	0.000299	0.000299	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—GNAS—bile duct cancer	0.000298	0.000298	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—GNAS—bile duct cancer	0.000298	0.000298	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—KRAS—bile duct cancer	0.000295	0.000295	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SMAD4—bile duct cancer	0.000293	0.000293	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SMAD4—bile duct cancer	0.000293	0.000293	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL6—bile duct cancer	0.000292	0.000292	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—bile duct cancer	0.000291	0.000291	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—EGFR—bile duct cancer	0.00029	0.00029	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—EGFR—bile duct cancer	0.00029	0.00029	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—KRAS—bile duct cancer	0.000285	0.000285	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—KRAS—bile duct cancer	0.000285	0.000285	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—KRAS—bile duct cancer	0.000283	0.000283	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—bile duct cancer	0.000281	0.000281	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—bile duct cancer	0.000281	0.000281	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NRAS—bile duct cancer	0.000281	0.000281	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GNAS—bile duct cancer	0.00028	0.00028	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—HRAS—bile duct cancer	0.000278	0.000278	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MMP9—bile duct cancer	0.000278	0.000278	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—ERBB2—bile duct cancer	0.000274	0.000274	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—KRAS—bile duct cancer	0.000274	0.000274	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—KRAS—bile duct cancer	0.000274	0.000274	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—HRAS—bile duct cancer	0.000269	0.000269	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—HRAS—bile duct cancer	0.000269	0.000269	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GNAS—bile duct cancer	0.000263	0.000263	CbGpPWpGaD
Loperamide—CALM3—Immune System—ERBB2—bile duct cancer	0.000262	0.000262	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TGFB1—bile duct cancer	0.000261	0.000261	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—HRAS—bile duct cancer	0.000258	0.000258	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—EGFR—bile duct cancer	0.000256	0.000256	CbGpPWpGaD
Loperamide—CALM2—Immune System—ERBB2—bile duct cancer	0.000253	0.000253	CbGpPWpGaD
Loperamide—CALM1—Immune System—ERBB2—bile duct cancer	0.000253	0.000253	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—HRAS—bile duct cancer	0.00025	0.00025	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL6—bile duct cancer	0.000247	0.000247	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NRAS—bile duct cancer	0.000246	0.000246	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—HRAS—bile duct cancer	0.000242	0.000242	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—HRAS—bile duct cancer	0.000242	0.000242	CbGpPWpGaD
Loperamide—CALM3—Disease—ERBB2—bile duct cancer	0.000242	0.000242	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—KRAS—bile duct cancer	0.000242	0.000242	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HRAS—bile duct cancer	0.00024	0.00024	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—IL6—bile duct cancer	0.00024	0.00024	CbGpPWpGaD
Loperamide—CALM3—Disease—PTGS2—bile duct cancer	0.000237	0.000237	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP9—bile duct cancer	0.000235	0.000235	CbGpPWpGaD
Loperamide—CALM1—Disease—ERBB2—bile duct cancer	0.000234	0.000234	CbGpPWpGaD
Loperamide—CALM2—Disease—ERBB2—bile duct cancer	0.000234	0.000234	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HRAS—bile duct cancer	0.000233	0.000233	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HRAS—bile duct cancer	0.000233	0.000233	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—IL6—bile duct cancer	0.000232	0.000232	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—IL6—bile duct cancer	0.000232	0.000232	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TGFB1—bile duct cancer	0.000229	0.000229	CbGpPWpGaD
Loperamide—CALM2—Disease—PTGS2—bile duct cancer	0.000229	0.000229	CbGpPWpGaD
Loperamide—CALM1—Disease—PTGS2—bile duct cancer	0.000229	0.000229	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—EGFR—bile duct cancer	0.000224	0.000224	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SLC5A5—bile duct cancer	0.000222	0.000222	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—NRAS—bile duct cancer	0.000218	0.000218	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—bile duct cancer	0.000215	0.000215	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—KRAS—bile duct cancer	0.000212	0.000212	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—NRAS—bile duct cancer	0.000211	0.000211	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—NRAS—bile duct cancer	0.000211	0.000211	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NRAS—bile duct cancer	0.000208	0.000208	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HRAS—bile duct cancer	0.000206	0.000206	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—bile duct cancer	0.000204	0.000204	CbGpPWpGaD
Loperamide—CALM3—Immune System—NRAS—bile duct cancer	0.000199	0.000199	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—EGFR—bile duct cancer	0.000199	0.000199	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—bile duct cancer	0.000198	0.000198	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—bile duct cancer	0.000197	0.000197	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TGFB1—bile duct cancer	0.000193	0.000193	CbGpPWpGaD
Loperamide—CALM2—Immune System—NRAS—bile duct cancer	0.000193	0.000193	CbGpPWpGaD
Loperamide—CALM1—Immune System—NRAS—bile duct cancer	0.000193	0.000193	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—EGFR—bile duct cancer	0.000192	0.000192	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—EGFR—bile duct cancer	0.000192	0.000192	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—bile duct cancer	0.000192	0.000192	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—bile duct cancer	0.000192	0.000192	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EGFR—bile duct cancer	0.00019	0.00019	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—bile duct cancer	0.000188	0.000188	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—KRAS—bile duct cancer	0.000188	0.000188	CbGpPWpGaD
Loperamide—CALM3—Disease—NRAS—bile duct cancer	0.000184	0.000184	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—KRAS—bile duct cancer	0.000182	0.000182	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—KRAS—bile duct cancer	0.000182	0.000182	CbGpPWpGaD
Loperamide—CALM3—Immune System—EGFR—bile duct cancer	0.000182	0.000182	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HRAS—bile duct cancer	0.00018	0.00018	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—KRAS—bile duct cancer	0.000179	0.000179	CbGpPWpGaD
Loperamide—CALM1—Disease—NRAS—bile duct cancer	0.000178	0.000178	CbGpPWpGaD
Loperamide—CALM2—Disease—NRAS—bile duct cancer	0.000178	0.000178	CbGpPWpGaD
Loperamide—CALM1—Immune System—EGFR—bile duct cancer	0.000176	0.000176	CbGpPWpGaD
Loperamide—CALM2—Immune System—EGFR—bile duct cancer	0.000176	0.000176	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—bile duct cancer	0.000172	0.000172	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—bile duct cancer	0.000172	0.000172	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GNAS—bile duct cancer	0.000172	0.000172	CbGpPWpGaD
Loperamide—CALM3—Immune System—KRAS—bile duct cancer	0.000172	0.000172	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFB1—bile duct cancer	0.000171	0.000171	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ERBB2—bile duct cancer	0.000169	0.000169	CbGpPWpGaD
Loperamide—CALM3—Disease—EGFR—bile duct cancer	0.000168	0.000168	CbGpPWpGaD
Loperamide—CALM2—Immune System—KRAS—bile duct cancer	0.000166	0.000166	CbGpPWpGaD
Loperamide—CALM1—Immune System—KRAS—bile duct cancer	0.000166	0.000166	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFB1—bile duct cancer	0.000165	0.000165	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFB1—bile duct cancer	0.000165	0.000165	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ERBB2—bile duct cancer	0.000164	0.000164	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ERBB2—bile duct cancer	0.000164	0.000164	CbGpPWpGaD
Loperamide—CALM2—Disease—EGFR—bile duct cancer	0.000162	0.000162	CbGpPWpGaD
Loperamide—CALM1—Disease—EGFR—bile duct cancer	0.000162	0.000162	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HRAS—bile duct cancer	0.00016	0.00016	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—bile duct cancer	0.000159	0.000159	CbGpPWpGaD
Loperamide—CALM3—Disease—KRAS—bile duct cancer	0.000158	0.000158	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HRAS—bile duct cancer	0.000154	0.000154	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HRAS—bile duct cancer	0.000154	0.000154	CbGpPWpGaD
Loperamide—CALM2—Disease—KRAS—bile duct cancer	0.000153	0.000153	CbGpPWpGaD
Loperamide—CALM1—Disease—KRAS—bile duct cancer	0.000153	0.000153	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—bile duct cancer	0.000153	0.000153	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HRAS—bile duct cancer	0.000152	0.000152	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—bile duct cancer	0.00015	0.00015	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—bile duct cancer	0.000148	0.000148	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—bile duct cancer	0.000148	0.000148	CbGpPWpGaD
Loperamide—CALM3—Immune System—HRAS—bile duct cancer	0.000146	0.000146	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—bile duct cancer	0.000146	0.000146	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—bile duct cancer	0.000145	0.000145	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—bile duct cancer	0.000141	0.000141	CbGpPWpGaD
Loperamide—CALM1—Immune System—HRAS—bile duct cancer	0.000141	0.000141	CbGpPWpGaD
Loperamide—CALM2—Immune System—HRAS—bile duct cancer	0.000141	0.000141	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—bile duct cancer	0.000141	0.000141	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—bile duct cancer	0.000141	0.000141	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—bile duct cancer	0.00014	0.00014	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—bile duct cancer	0.000135	0.000135	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—bile duct cancer	0.000135	0.000135	CbGpPWpGaD
Loperamide—CALM3—Disease—HRAS—bile duct cancer	0.000135	0.000135	CbGpPWpGaD
Loperamide—CALM1—Disease—HRAS—bile duct cancer	0.00013	0.00013	CbGpPWpGaD
Loperamide—CALM2—Disease—HRAS—bile duct cancer	0.00013	0.00013	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NRAS—bile duct cancer	0.000129	0.000129	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—bile duct cancer	0.000129	0.000129	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NRAS—bile duct cancer	0.000125	0.000125	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NRAS—bile duct cancer	0.000125	0.000125	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—bile duct cancer	0.000125	0.000125	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—bile duct cancer	0.000125	0.000125	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFB1—bile duct cancer	0.00012	0.00012	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EGFR—bile duct cancer	0.000117	0.000117	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFB1—bile duct cancer	0.000116	0.000116	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFB1—bile duct cancer	0.000116	0.000116	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EGFR—bile duct cancer	0.000114	0.000114	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EGFR—bile duct cancer	0.000114	0.000114	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—KRAS—bile duct cancer	0.000111	0.000111	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—KRAS—bile duct cancer	0.000107	0.000107	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—KRAS—bile duct cancer	0.000107	0.000107	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—bile duct cancer	9.86e-05	9.86e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—bile duct cancer	9.54e-05	9.54e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—bile duct cancer	9.54e-05	9.54e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HRAS—bile duct cancer	9.43e-05	9.43e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—bile duct cancer	9.25e-05	9.25e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HRAS—bile duct cancer	9.12e-05	9.12e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HRAS—bile duct cancer	9.12e-05	9.12e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—bile duct cancer	9.02e-05	9.02e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—bile duct cancer	8.73e-05	8.73e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—bile duct cancer	8.73e-05	8.73e-05	CbGpPWpGaD
